Hematologist-oncologist Sergio Giralt was featured on this special episode of 20/20 that took viewers on a journey inside Good Morning America co-host Robin Roberts’s fight against myelodysplastic syndrome. Robin received a stem cell transplant to treat her disease at Memorial Sloan-Kettering.
Good Morning America co-host Robin Roberts discussed her return to the program after receiving a stem cell transplant at Memorial Sloan-Kettering with hematologist-oncologist Sergio Giralt, who led her treatment team. Her nurses were also featured on the program.
The Breakthrough Prize in Life Sciences – a new award established by Art Levinson, Sergey Brin, Anne Wojcicki, Mark Zuckerberg, Priscilla Chan, and Yuri Milner – was awarded to physician-scientist Charles Sawyers.
Gynecologic oncologist Martee Hensley discussed the importance of fundraising events like Cycle for Survival, which raises money for rare cancer research at Memorial Sloan-Kettering.
Visible Ink founder Judith Kelman discussed the Memorial Sloan-Kettering program she runs that connects patients with experienced writers, editors, and teachers to help them tell their stories in writing.
Medical oncologist Michael Morris commented on a study that found that men with high-risk prostate cancer treated with only 18 months of hormone therapy live just as long as those treated for a standard 36 months.
Medical oncologists Mark Kris and Larry Norton and cancer biologist Joan Massagué discussed a revolution currently taking place in cancer care – tailoring treatments for specific individuals based on their tumor’s molecular makeup.
Medical oncologist Kenneth Yu spoke about a study he led that suggests that a simple blood test may be able to predict which chemotherapy regimen will work for some patients with pancreatic cancer.
Claudia Ayash, co-director of Memorial Sloan-Kettering’s Arab American Breast Cancer Education and Referral Program, spoke about the breast cancer screening obstacles some Arab American women face.
